Larimar Therapeutics, Inc. (LRMR) Earnings Call Transcripts

3 earnings calls from September 2025 to June 29, 2026

NasdaqGM US Health Care Biotechnology

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. (LRMR) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 3 calls on record spanning September 29, 2025 to June 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 3 Larimar Therapeutics, Inc. earnings call transcripts on record, spanning September 29, 2025 to June 29, 2026. Based on this history, Larimar Therapeutics, Inc. reports semi-annually. The most recent call on file is dated June 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LRMR
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
3
First call
September 29, 2025
Most recent
June 29, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Jun 29, 2026 Read transcript
Company Conference Presentations Jan 14, 2026 Read transcript
Special Calls Sep 29, 2025 Read transcript